Skip to main content
    A

    AstraZeneca PLC (AZN)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - GENERAL • NYSE

    $182.36
    -1.66 (-0.90%)

    Market Cap: $286.07B

    Last updated: Nov 17, 2026 at 4:43 PM ET

    AstraZeneca PLC (AZN) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    AstraZeneca (AZN) has a latest price of $182.36 on Nov 17, 2026, 12.8% below its 52-week high of $209.11. Its price rose 4.5% over the past 12 months. The month-end price rose 229.5% over the 10 years through Oct 2026, a compound annual rate of 12.7%.

    Price Chart

    From Oct 2016 to Oct 2026, its highest month-end close was $208.45 in Feb 2026 and its lowest $52.28 in Nov 2016, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart AZN with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for AZN.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price rose 10.6%, and over 6 months it fell 0.6%. The month-end price rose 47.6% over the 3 years through Oct 2026, a compound annual rate of 13.9%.

    PeriodChange
    1 month+11.2%
    3 months+10.6%
    6 months-0.6%
    12 months+4.5%
    12 months, with dividends+7.6%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years+47.6%+13.9%
    5 years+49.6%+8.4%
    10 years+229.5%+12.7%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2025, when the price rose 40.3%, and its weakest was 2024, when it fell 2.7%.

    YearCloseChange
    2026 through Oct 2026$186.65+1.5%
    2025$183.86+40.3%
    2024$131.04-2.7%
    2023$134.70-0.7%
    2022$135.60+16.4%
    2021$116.50+16.5%
    2020$99.98+0.3%
    2019$99.72+31.3%
    2018$75.96+9.5%
    2017$69.40+27.0%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 7.5% above its 50-day average of $169.68 and 1.7% above its 200-day average of $179.34.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$182.36
    52-week high$209.11-12.8%
    52-week low$152.40+19.7%
    50-day average$169.68+7.5%
    200-day average$179.34+1.7%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 27.9%.

    MeasureValue
    1-year beta0.22
    Largest fall, 1 year-25.8%
    Largest fall, 3 years-27.9%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Valuation

    AstraZeneca traded at 30.9x earnings at the end of 2025, against a 5-year median of 37.6x and a 10-year median of 39.7x.

    AZN valuation history

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About AZN

    What is AZN's 1-year price change?

    AstraZeneca's price rose 4.5% over the past 12 months. With dividends included, the 12-month total return was 7.6%.

    What is AZN's 5-year price change?

    AstraZeneca's month-end price rose 49.6% over the 5 years through Oct 2026, a compound annual rate of 8.4%. These figures leave out dividends.

    What is AZN's 52-week high and low?

    AstraZeneca's 52-week high is $209.11 and its 52-week low is $152.40. Its latest price of $182.36 on Nov 17, 2026 is 12.8% below the high.

    What is AZN's beta?

    AstraZeneca's 1-year beta against the S&P 500 is 0.22, so its price has moved less than the market over the past year. Its largest fall from a peak over the past year was 25.8%.

    Is the AZN chart free?

    Yes. Advanced Charting for AZN is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.